Skip to Content
MilliporeSigma
All Photos(2)

Key Documents

View All Documentation

SML3804

Sigma-Aldrich

PMX205 trifluoroacetate

≥98% (HPLC)

Synonym(s):

Hydrocinnamate (HC)-[OP(D-Cha)WR] trifluoroacetate, (5→1)-lactam-N2-(1-oxo-3-phenylpropyl)-L-ornithyl-L-prolyl-3-cyclohexyl-D-alanyl-L-tryptophyl-L-arginine trifluoroacetate, HC-[OP(D-Cha)WR] trifluoroacetate, HC-[Orn-Pro-dCha-Trp-Arg] trifluoroacetate, Hydrocinnamate-(L-ornithine-proline-D-cyclohexylalanine-tryptophan-arginine) trifluoroacetate;, Hydrocinnamate-(OPdChaWR) trifluoroacetate, Hydrocinnamate-[OP(D-Cha)WR] trifluoroacetate, PMX 205 trifluoroacetate, PMX-205 trifluoroacetate, c[Arg-Trp-D-Cha-Pro-Orn]-Hca trifluoroacetat

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Empirical Formula (Hill Notation):
C45H62N10O6 · xC2HF3O2
Molecular Weight:
839.04 (free base basis)
MDL number:
MFCD31735786
UNSPSC Code:
51111800
UNSPSC Code:
12352200
NACRES:
NA.21

Quality Level

100

Assay

≥98% (HPLC)

form

(Powder or Lyophilized powder or film)

storage condition

desiccated

color

white to off-white

storage temp.

-10 to -25°C

Biochem/physiol Actions

PMX205 is a blood-brain barrier (BBB)-permeable and orally active cyclic hexapeptide that acts as a high-affinity and potent antagonist against complement C5a receptor C5aR1. Unlike its structural analog PMX53, PMX205 is resistant to intestinal metabolism and shows 10-30-times higher in vivo efficacy when administered orally (mortality rate = 1/9 with 0.1 mg/kg/day PMX205 vs. 2/10 with 1 mg/kg/day PMX53 in a rat colitis model) despite similar in vitro potency (PMX205/PMX53 pIC50 = 6.50/6.38 against 50 pM C5a by competitive binding, 9.03/8.24 against C5a-induced human PMN MPO release). PMX205 shows in vivo efficacy in animal models of AD (3-6 mg/kg/day p.o., mice), ALS (1 mg/kg/day p.o., rats), and HD (10 mg/kg/day p.o., rats).

Caution

Hygroscopic

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration
Faseb Journal, 20(9), 1407-1417 (2006)
Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease
Journal of immunology (Baltimore, Md. : 1950), 183(2), 1375-1383 (2009)
Trent M Woodruff et al.
The Journal of pharmacology and experimental therapeutics, 314(2), 811-817 (2005-05-10)
We have previously shown that complement factor 5a (C5a) plays a role in the pathogenesis of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats by using the selective, orally active C5a antagonist AcF-[OP(d-Cha)WR]. This study tested the efficacy and potency of

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service